Home

  • How Autonomous Will the Supply Chain Be?ByPatricia Van Arnum

    How Autonomous Will the Supply Chain Be?
    By

    A recent analysis by Gartner projects low uptake of AI for autonomous supply-chain planning decisions by 2030, but AI does factor into the workflows of the top 25 supply-chain organizations according to the firm’s annual rankings, but how?


  • Novo at a Crossroads: Will Its Strategic Plan Deliver?ByPatricia Van Arnum

    Novo at a Crossroads: Will Its Strategic Plan Deliver?
    By

    Novo’s CEO Mike Doustdar laid out a strategic growth plan for the company, which included a plan to launch more than five multi-blockbusters by 2030 and expand beyond its obesity and diabetes franchise. Will he and the company be able to deliver?


  • Innovation & Pharma: The Molecules & CompaniesByPatricia Van Arnum

    Innovation & Pharma: The Molecules & Companies
    By

    How truly innovative is the bio/pharma industry? What products, modalities, and companies are behind that innovation? Looking at “first-in-class” new drug approvals, defined as drugs with new mechanisms of action over existing drugs, reveals an interesting picture.


DCAT MEMBER COMPANY COMMUNITY

  • DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair   
    By

    The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the world’s largest international pre-college student science and engineering competition that took place in Phoenix, Arizona from May 9–15, 2026.   Owned and produced by the Society for Science, Regeneron…

  • ICYMI: Production to Prescription Podcast: A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis 
    By

    The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving?  In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a roundtable of industry experts share their perspectives on the latest in peptide synthesis.   Solid-phase peptide synthesis (SPPS) is the dominant method in peptide synthesis, but other approaches, such…

  • New DCAT Member Company Alert
    By

    Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all DCAT Member Companies, visit the Member Directory at the DCAT website. From the May 8, 2026, issue of  DCAT Value Chain Insights: From the May…

  • People on the Move
    By

    Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the March 6, 2026, issue of DCAT Value Chain Insights: From the January 30, 2026, issue of DCAT Value Chain Insights: